Recent evidence shows that inhibiting the SDF-1/CXCR4 axis attenuates hypoxia-induced PAH in neonatal mice by reversing pulmonary vascular cell proliferation [12]. Here, CXCR4 is linked to pulmonary arterial hypertension.